​​Effectiveness of mRESVIA Against Serious Endpoints related to RSV in Kaiser Permanente Northern California (ERASE-RSV)​

26/03/2026
26/03/2026
EU PAS number:
EUPAS1000000946
Study
Ongoing
Documents
Study protocol
Study results
Study report
Other information